The General Hospital Corporation recalls Fludeoxyglucose F 18 Injection, 20-300 mCi/mL at End of Synthesis (EOS) Solution, 50 mL glass vial, Rx only, Manufacture
Recalled March 3, 2021 · FDA recall D-0288-2021 · The General Hospital
Hazard
Lack of Assurance of Sterility · FDA Class II
Units
50 mL vial
Sold at
Product was distributed to one direct account.
Description
Lack of Assurance of Sterility
Product
Fludeoxyglucose F 18 Injection, 20-300 mCi/mL at End of Synthesis (EOS) Solution, 50 mL glass vial, Rx only, Manufactured by Massachusetts General Hospital PET Center, Boston, MA NDC 76318-334-50
Manufacturer(s)
The General Hospital Corporation
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →